NCT01751360View on ClinicalTrials.gov

SYR-472 Open-label Study

PHASE3CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

April 1, 2013

Primary Completion Date

August 1, 2013

Study Completion Date

August 1, 2013

Conditions

Diabetes Mellitus

Interventions

DRUG

SYR-472

Trial Locations (1)

Unknown

Suita-shi

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY